期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清Cys C、尿NAG、尿mAlb对监测DM2早期肾功能损害的价值 被引量：2

暂未订购
导出
摘要 糖尿病及其并发症严重影响患者的生活质量。肾脏病变在糖尿病患者中的发病率和死亡率均很高，约20％-4JD％的糖尿病患者最终发展为糖尿病肾病（DN），检测血清胱抑素C（CysC）、肌酐（Cr）、尿N-乙酰-β—D-氨基葡萄糖苷酶（NAG）、尿微量白蛋白（mAlb）等项目，能反映早期肾脏损害及其程度，现报道如下。
作者 雷光文 衡爱萍
机构地区 解放军第三医院检验科(兰州军区检验中心) 解放军第三医院军人接诊站
出处 《放射免疫学杂志》 CAS 2011年第1期97-98,共2页 Journal of Radioimmanology
关键词 血清CYSC 尿NAG 早期肾功能损害 DM2 糖尿病肾病 氨基葡萄糖苷酶 价值 监测
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献5

二级参考文献26

  • 1苏彩芳,高岩.血清胱抑素C测定临床意义探讨[J].中国病案,2006,7(6):47-48. 被引量：28
  • 2巩继勇,胡剑.糖尿病肾病患者检测血清胱抑素C的临床意义[J].浙江实用医学,2007,12(1):3-4. 被引量：30
  • 3李培敏,陶庆枢.血清胱抑素C与超敏C反应蛋白联检诊断早期糖尿病肾损伤的价值[J].现代医院,2007,7(4):19-19. 被引量：34
  • 4[1]Shemesh O, Golbetz H, et al. Limitations of creatinine as a filtration marker in glomerulopathic patients[J]. Kidney Int, 1985;28:830～838.
  • 5[2]Perrone RD, Madias NE, et al. Serum creatinine as an index of renal function: new insights into old concepts [J]. Clin Chem,1992;38:1933～1953.
  • 6[3]Jacobsson B, Lignelid H, et al. Transthyretin and cyststin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas [J].Histopathology, 1995; 16:559～564.
  • 7[4]Abrahamson M, Olafsson I, et al. Structure and expression of the human cystatin C gene[J]. Biochem J,1990;268:287～294.
  • 8[5]Grubb A, Simonsen O, et al. Serum concentratuon of cystatin C,factor D and β2-microglobulin as a measure of glomerular filtration rate[M]. Acta Med Scand, 1985;218:499～503.
  • 9[6]Kyhse Andersen J, Schmidt C, et al. Serum cystatin C,determined by a rapid, automated particle -enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate[J]. Clin Chem, 1994;40:1921～1926.
  • 10[7]Finney H, Newman DJ, et al. Initial evaluation of cystatin C measurement by particleenhanced immunonephelometry on the Behring nephelometer systems (BNA.BN Ⅱ )[J]. Clin Chem,1997;43:1016～1022.

共引文献412

同被引文献53

  • 1邱谷,黄桥林,陈红梅,戴世荣,张骆军.Cystatin C和NAG测定在糖尿病肾损害诊断中的作用[J].检验医学与临床,2007,4(3):180-182. 被引量：5
  • 2Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China [J]. N Engl J Med, 2010, 362(12): 1090.
  • 3Narita T, Hosoba M, Kakei M, et al. Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes [J]. Diabetes Care, 2006, 29(1): 142.
  • 4Bangstad H J, Seljeflot I, Berg T J, et al. Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes [J]. Scand J Clin Lab Invest, 2009, 69(1): 138.
  • 5Phillips A O, Steadman R. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury [J]. Histol Histopathol, 2002, 17(1): 247.
  • 6Moresco R N, Sangoi M B, De Carvalho J A, et al. Diabetic nephropathy: traditional to proteomic markers [J]. Clin Chim Acta, 2013, 421: 17.
  • 7Vaidya V S, Niewczas M A, Ficociello L H, et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase [J]. Kidney Int, 2011, 79(4): 464.
  • 8Kamijo-Ikemori A, Sugaya T, Yasuda T, et al. Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients [J]. Diabetes Care, 2011, 34(3): 691.
  • 9Kim S S, Song S H, Kimn I J, et al. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients [J]. Diabetes Res Clin Pract, 2012, 97(2): 251.
  • 10Thomas M C, Burns W C, Cooper M E. Tubular changes in early diabetic nephropathy [J]. Adv Chronic Kidney Dis, 2005, 12(2): 177.

引证文献2

二级引证文献24

放射免疫学杂志
2011年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部